img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
June 24, 2021
img
img
Grove, Inc.
(Nasdaq: GRVI)

$12,650,000

Initial Public Offering

Sole Bookrunner

June 18, 2021
img
img
Sonim Technologies, Inc.
(Nasdaq: SONM)

$10,000,000

ATM Offering
Sales Agent

June 16, 2021
img
The Glimpse Group, Inc.
(Nasdaq: VRAR)

$14,087,500

Initial Public Offering
Sole Bookrunner

June 15, 2021
img
img
Synchronoss Technologies, Inc.
(Nasdaq: SNCR)

$125,000,000

Senior Notes

Lead Manager

June 12, 2021
img
img
Grom Social Enterprises, Inc.
(Nasdaq: GROM)

$11,496,384

Underwritten Public
Offering and Uplisting
Sole Bookrunner

June 1, 2021
img
img
Taronis Fuels, Inc.
(OTCQB: TRNF)

$16,496,004

Private Placement
Executive Placement Agent

June 1, 2021
img
img
CEL-SCI Corporation
(NYSE: CVM)

$36,418,200

Bought Underwritten Public Offering
Sole Bookrunner

June 1, 2021
img
img
Atlanticus Holdings Corporation
(Nasdaq: ATLC)

$79,713,325

Preferred Stock Offering
Lead Manager

June 1, 2021
img
img
American Resources Corporation
(Nasdaq: AREC)

$30,100,000

Registered Direct
Exclusive Placement Agent

June 1, 2021
img
img
Global Consumer Acquisition Company
(Nasdaq: GACQU)

$182,630,000

SPAC IPO
Sole Bookrunner

June 1, 2021
img
img
Splash Beverage Group Inc.
(NYSE: SBEV)

$15,000,000

Uplisting
and Underwritten Public Offering
Sole Bookrunner

May 1, 2021
img
img
Alfi, Inc.
(Nasdaq: ALF)

$17,807,840

Initial Public Offering
Sole Bookrunner

1 23 24 25 26 27 34
Insights
  • April 9, 2025

    D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in connection with its $4.0 Million Initial Public Offering

  • March 27, 2025

    D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

  • March 26, 2025

    D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

  • March 4, 2025

    D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

img

Together, let's build meaningful value.